The many facets of metzincins and their endogenous inhibitors : Perspectives on ovarian cancer progression
Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells
Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells : Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
Are you sure you would like to clear your session, including search history and login status?